Pfizer announced a $6.7 billion deal to expand cannabinoid treatments, involving Arena Pharmaceuticals. Concurrently, OSRAM and Godox are leveraging market trends influenced by the International Energy Agency in Switzerland.

The entities involved

• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Arena Pharmaceuticals →

  American biopharmaceutical company

  Nothing else this week.

• Switzerland →

  country in Central Europe

  • ECB has established swap line arrangements with central banks, with the ECB President leading central bank operations.Mon 17:35
  • Talks regarding an Iran deal are underway, with a ceasefire reached after deadly exchanges, and Trump supporting Israel.Mon 17:12

Related events

• FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.Aug 18
• Pfizer, Johnson & Johnson, and Merck are facing significant industry pressures due to patent cliffs and market pricing demands.Wed 15:27
• Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.Aug 26
• Pfizer is jointly marketing the drug Eliquis.Jun 13
• Alnylam and BridgeBio received label expansion approvals in the EU, while Pfizer's therapies compete in the ATTR-CM market.Jun 7